ITOS - iTeos to Participate in Upcoming Investor Conferences | Benzinga
WATERTOWN, Mass. and GOSSELIES, Belgium, Sept. 06, 2023 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (NASDAQ:ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients, today announced that company management will participate in two upcoming investor conferences in September:
H.C. Wainwright 25th Annual Global Investment Conference
Format: Fireside chat and one-on-one investor meetings
Date: Wednesday, September 13, 2023
Time: 12:30 – 1:00 PM ET
Location: New York, N.Y.
Cantor Global Healthcare Conference 2023
Format: Fireside chat and one-on-one investor meetings